AMELUZ®

treatment of actinic keratosis and basal cell carcinoma.

treatment of actinic keratosis and basal cell carcinoma.

Ameluz contains the active substance 5‑aminolevulinic acid. It is used in the treatment of:

  • mild to moderately thick actinic keratosis or whole areas affected by actinic keratosis in adults. Actinic keratosis are certain changes in the outer layer of the skin, which can lead to skin cancer.
  • superficial and/or nodular basal cell carcinoma that is not suitable for surgical treatment due to possible treatment-related morbidity and/or poorer cosmetic outcome in adults. Basal cell carcinoma is a skin cancer that can cause reddish, scaly patches or one or more lumps that bleed easily and do not heal.

After application, the active substance in Ameluz becomes a photoactive substance that accumulates in affected cells.

Illumination with appropriate light produces reactive oxygen-containing molecules that act on the target cells. This treatment is called photodynamic therapy (PDT).